Replimune (REPL) Tax Provisions (2023 - 2026)
Replimune (REPL) posted Tax Provisions of -$289000.0 for Q1 2026, up 3.67% sequentially from -$300000.0 in Q4 2025, and down 285.33% YoY from $155935.3 in Q1 2025.
Powered by 
Analysis
Replimune (REPL) Tax Provisions (2023 - 2026) Analysis & Trends
Replimune has reported Tax Provisions for 4 years, with the latest figure at -$289000.0 in Q1 2026.
- Quarterly Tax Provisions fell 285.33% year-over-year to -$289000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$89000.0 (down 117.8% YoY) and the FY2026 annual result came in at -$600000.0, down 220.0% from the prior year.
- Tax Provisions climbed to -$289000.0 in Q1 2026 per REPL's latest filing, from -$300000.0 in the prior quarter.
- Over five years, Tax Provisions peaked at $575000.0 in Q4 2024 and troughed at -$300000.0 in Q4 2025.
- A 4-year average of $68777.8 and a median of -$65000.0 in 2024 frame the typical range for Tax Provisions.
- The sharpest annual moves came in 2024 and 2026: Tax Provisions rose 21.56% in 2024, then tumbled 285.33% in 2026.
- Over 4 years, Tax Provisions stood at $473000.0 in 2023, then grew by 21.56% to $575000.0 in 2024, then sank by 152.17% to -$300000.0 in 2025, then gained by 3.67% to -$289000.0 in 2026.
- According to Business Quant data, Tax Provisions over the past three periods registered -$289000.0, -$300000.0, and -$75000.0 for Q1 2026, Q4 2025, and Q1 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.87 Bn | 131.01 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 85.57 Bn | 77.57 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | -59.00 Mn |
| 4 | Moderna | 58.19 Bn | 53.05 Bn | 52.00 Mn | 15.00 Mn |
| 5 | Revolution Medicines | 44.07 Bn | 44.07 Bn | - | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn | 75.45 Mn |
| 7 | Alnylam Pharmaceuticals | 35.38 Bn | 32.07 Bn | 992.69 Mn | 13.31 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | - |
| 9 | Insmed | 27.41 Bn | 26.25 Bn | 358.27 Mn | 1.90 Mn |
| 10 | Replimune | 1.45 Bn | 1.45 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -289,000.00 |
| Dec 31, 2025 | -311,000.00 |
| Mar 31, 2025 | -100,000.00 |
| Dec 31, 2024 | 600,000.00 |
| Mar 31, 2024 | -92,000.00 |
| Dec 31, 2023 | 500,000.00 |
| Sep 30, 2023 | -201,000.00 |
| Jun 30, 2023 | 201,000.00 |
| Mar 31, 2023 | 300,000.00 |